MedPath

Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition

Phase 3
Completed
Conditions
Jawline Definition
Registration Number
NCT03712137
Lead Sponsor
Allergan
Brief Summary

This study will evaluate the safety and effectiveness of JUVÉDERM VOLUX™ XC injectable gel for restoring jawline definition

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
206
Inclusion Criteria
  • Has "Moderate" or "Severe" loss of jawline definition as determined by the EI using the ALJDs (Grade 2 or 3 on the ALJDS) on both sides. The grade does not have to be the same on both sides, but must be Grade 2 or 3
  • Treating Investigator (TI) considers the subject's jaw amenable to an improvement of at least 1 grade on the scale for the jawline definition
  • Written Informed Consent (IC) has been obtained
Exclusion Criteria
  • Has ever received permanent facial implants (eg, polymethylmethacrylate, silicone, polytetrafluoroethylene) anywhere in the face or neck, or is planning to be implanted with any of these products during the study
  • Has ever undergone fat injections in the malar, chin or jawline area or is planning to undergo this procedure during the study
  • Has undergone semipermanent dermal filler treatment (eg, calcium hydroxyapatite, poly-L-lactic acid) below the subnasale within 36 months before enrollment or is planning to undergo such treatment during the study
  • Has received deoxycholic acid treatment in the submental region in the last 6 months
  • Has active autoimmune disease
  • Females who are pregnant, nursing, or planning a pregnancy during the course of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Who Show ≥ 1-point Jawline Improvement on Both Sides From Baseline on the Allergan Loss of Jawline Definition Scale (ALJDS)Month 6

The ALJDS is an Investigator assessment of loss of jawline definition measured by a 5-point scale (0=None, 1=Mild, 2=Moderate, 3=Severe, 4=Extreme)

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants Who Note "Improved" or "Much Improved" in Jawline Area as Assessed by the Evaluating Investigator Using the Global Aesthetic Improvement Scale (GAIS)Month 6

The Evaluating Investigator (EI) will assess the aesthetic improvement of the jawline area using the GAIS 5-point scale where: 2=much improved, 1=improved, 0=no change, -1=worse and -2=much worse. The percentage of participants who the Evaluating Investigator assesses as 2=much improved or 1=improved will be reported.

Percentage of Participants Who Note "Improved" or "Much Improved" in Jawline Area as Assessed by the Participant Using the Global Aesthetic Improvement Scale (GAIS)Month 6

The participant will assess the aesthetic improvement of the jawline area using the GAIS 5-point scale where: 2=much improved, 1=improved, 0=no change, -1=worse and -2=much worse. The percentage of participants who assess themselves as 2=much improved or 1=improved will be reported.

Change From Baseline in Overall Score for FACE-Q™ Satisfaction With Lower Face and Jawline ScoreBaseline to Month 6

The subject will assess satisfaction using the 5 questions on the Satisfaction of Lower Face and Jawline scale of the FACE-Q™ questionnaire measured on a 4-point scale (1=Very Dissatisfied 2=Somewhat Dissatisfied, 3=Somewhat Satisfied, 4=Very Satisfied). The raw scale summed score will then be converted into a Rasch-transformed score from 0 (worst) to 100 (best)

Trial Locations

Locations (19)

Total Skin and Beauty Dermatology Center, PC

🇺🇸

Birmingham, Alabama, United States

Westside Aesthetics

🇺🇸

Los Angeles, California, United States

Artemedica

🇺🇸

Santa Rosa, California, United States

Center for Dermatology and Dermatologic Surgery

🇺🇸

Washington, District of Columbia, United States

Susan H Weinkle, MD

🇺🇸

Bradenton, Florida, United States

Hevia Cosmetic Dermatology

🇺🇸

Coral Gables, Florida, United States

Skin Research Institute LLC

🇺🇸

Coral Gables, Florida, United States

Baumann Cosmetic and Research Institute

🇺🇸

Miami, Florida, United States

DeNova Research dba Arano, LLC

🇺🇸

Chicago, Illinois, United States

Callender Center for Clinical Research

🇺🇸

Glenn Dale, Maryland, United States

Scroll for more (9 remaining)
Total Skin and Beauty Dermatology Center, PC
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.